Mauro, P. M., Gutkind, S., Annunziato, E. M., & Samples, H. (2022). Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019. JAMA Network Open, 5(3), e223821. https://doi.org/10.1001/jamanetworkopen.2022.3821

Rudolph, K. E., Shulman, M., Fishman, M., Díaz, I., Rotrosen, J., & Nunes, E. V. (2021). Association between dynamic dose increases of buprenorphine for treatment of opioid use disorder and risk of relapse. Addiction, 117(3), 637–645. Portico. https://doi.org/10.1111/add.15654

Rudolph, K. E., Díaz, I., Luo, S. X., Rotrosen, J., & Nunes, E. V. (2021). Optimizing opioid use disorder treatment with naltrexone or buprenorphine. Drug and Alcohol Dependence, 228, 109031. https://doi.org/10.1016/j.drugalcdep.2021.109031

Joudrey, P. J., Bart, G., Brooner, R. K., Brown, L., Dickson-Gomez, J., Gordon, A., Kawasaki, S. S., Liebschutz, J. M., Nunes, E., McCarty, D., Schwartz, R. P., Szapocnik, J., Trivedi, M., Tsui, J. I., Williams, A., Wu, L.-T., & Fiellin, D. A. (2021). Article Commentary: Research Priorities for Expanding access to Methadone Treatment for Opioid use Disorder in the United States: A National Institute on Drug Abuse Clinical Trials Network Task Force Report. Substance Abuse, 42(3), 245–254. https://doi.org/10.1080/08897077.2021.1975344